Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

NCT00171717 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Maintenance Liver Transplant Patients With New Onset Diabetes

Interventions

DRUG: Cyclosporine - cyclosporine microemulsion

Sponsor

Novartis